🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Functional Benefits of Multisite Upper Limb Surgery in Children With Unilateral Cerebral Palsy (RETRO-CHIRc)

Recruitingn/aAges any - 17 YearsAllCentre Médico-Chirurgical de Réadaptation des Mas…
NCT07891078 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This retrospective study evaluates the functional impact of individualized multisite neuro-orthopedic upper limb surgery in children with unilateral cerebral palsy (hemiplegic CP). Using a before-and-after design in which each patient serves as their own control, the study analyzes data collected in routine clinical care up to 3-5 years before and 1-2 years after surgery. The primary outcome is upper limb function as measured by the Modified Melbourne Assessment (MA2), which assesses range of motion and dexterity. Secondary outcomes include unimanual precision and fluidity (MA2), global manual dexterity (Box and Block Test), bimanual performance (Assisting Hand Assessment), and patient/parent satisfaction. Approximately 70 patients operated at the Centre Médico-Chirurgical de Réadaptation des Massues between January 2012 and June 2025 will be included. The study also aims to identify fac

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
INCLUSION CRITERIA * Minor patient (age \< 18 years at the time of the surgical project) * Unilateral upper limb involvement due to Cerebral Palsy * Having undergone neuro-orthopedic upper limb surgery * Surgery performed by the surgeon who participated in the multidisciplinary surgical planning meeting (EMC) * Surgery performed between January 1, 2012 and June 30, 2025 * Availability of at least one pre-operative assessment and one comparative post-operative assessment at more than 12 months after surgery * Followed at the CMCR des Massues NON-INCLUSION CRITERIA * Refusal of medical data processing for research purposes
💊

What it tests

  • Not listed
📍

Where

1 site
Centre Médico chirurgical de Réadaptation des Massues
Lyon, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy